Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2012	Dec. 31, 2011
Current Assets:
Cash	$ 775,399	$ 585,357
Trade accounts receivable net of allowance for doubtful accounts of approximately $135,000 and $75,000 at September 30, 2012 and December 31, 2011, respectively	5,912,093	2,563,089
Receivables due from affiliated companies	335,746	495,130
Inventories, net	9,535,285	9,627,798
Prepaid expenses and other current assets	536,621	424,168
Deferred tax asset	134,030	65,797
Total Current Assets	17,229,174	13,761,339
Property, plant and equipment, net	5,100,690	5,213,333
Other Assets:
Trademarks, trade names and patents, net	832,056	870,642
Other assets	25,591	33,442
Total Other Assets	857,647	904,084
Total Assets	23,187,511	19,878,756
Current Liabilities:
Accounts payable – trade	2,274,721	1,162,143
Revolving line of credit	1,700,000	850,000
Current portion of long term debt	404,271	400,430
Income taxes payable	33,381	353,608
Accrued expenses payable	980,370	889,444
Total Current Liabilities	5,392,743	3,655,625
Deferred tax liability	296,351	250,191
Long term debt, less current portion	1,634,906	1,939,362
Total Liabilities	7,324,000	5,845,178
Commitments and contingencies
Shareholders' Equity:
Common stock - $.01 par value, 12,000,000 shares authorized; 8,640,116 and 8,458,389 shares issued at September 30, 2012 and December 31, 2011, respectively	86,401	84,584
Additional paid in capital	8,516,870	8,163,864
Less cost of common stock in treasury, 351,503 shares at September 30, 2012 and December 31, 2011, respectively	(288,013)	(288,013)
Foreign currency translation adjustment	(261,728)	(268,084)
Retained earnings	7,556,770	6,058,848
Total Shareholders' Equity of Ocean Bio-Chem, Inc.	15,610,300	13,751,199
Noncontrolling interest	253,211	282,379
Total Shareholders' Equity	15,863,511	14,033,578
Total Liabilities and Shareholders' Equity	$ 23,187,511	$ 19,878,756